Bhagyanagar India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:18 pm

Competitors of Bhagyanagar India Ltd

All Competitor Stocks of Bhagyanagar India Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:25 pm

Below is a detailed analysis of the quarterly data for Bhagyanagar India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 485.60 Cr.. The value appears strong and on an upward trend. It has increased from 453.90 Cr. (Mar 2025) to 485.60 Cr., marking an increase of 31.70 Cr..
• For Expenses, as of Jun 2025, the value is 469.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 442.54 Cr. (Mar 2025) to 469.41 Cr., marking an increase of 26.87 Cr..
• For Operating Profit, as of Jun 2025, the value is 16.19 Cr.. The value appears strong and on an upward trend. It has increased from 11.36 Cr. (Mar 2025) to 16.19 Cr., marking an increase of 4.83 Cr..
• For OPM %, as of Jun 2025, the value is 3.33%. The value appears strong and on an upward trend. It has increased from 2.50% (Mar 2025) to 3.33%, marking an increase of 0.83%.
• For Other Income, as of Jun 2025, the value is 2.98 Cr.. The value appears strong and on an upward trend. It has increased from 1.66 Cr. (Mar 2025) to 2.98 Cr., marking an increase of 1.32 Cr..
• For Interest, as of Jun 2025, the value is 7.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.97 Cr. (Mar 2025) to 7.30 Cr., marking an increase of 2.33 Cr..
• For Depreciation, as of Jun 2025, the value is 1.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.01 Cr. (Mar 2025) to 1.77 Cr., marking a decrease of 0.24 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.10 Cr.. The value appears strong and on an upward trend. It has increased from 6.04 Cr. (Mar 2025) to 10.10 Cr., marking an increase of 4.06 Cr..
• For Tax %, as of Jun 2025, the value is 24.95%. The value appears to be increasing, which may not be favorable. It has increased from 24.17% (Mar 2025) to 24.95%, marking an increase of 0.78%.
• For Net Profit, as of Jun 2025, the value is 7.57 Cr.. The value appears strong and on an upward trend. It has increased from 4.58 Cr. (Mar 2025) to 7.57 Cr., marking an increase of 2.99 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.37. The value appears strong and on an upward trend. It has increased from 1.43 (Mar 2025) to 2.37, marking an increase of 0.94.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:36 am

Growth

Last Updated: September 5, 2025, 12:45 am

Balance Sheet

Last Updated: June 16, 2025, 12:23 pm

Below is a detailed analysis of the balance sheet data for Bhagyanagar India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 187.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 14.00 Cr..
• For Borrowings, as of Mar 2025, the value is 275.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 101.00 Cr. (Mar 2024) to 275.00 Cr., marking an increase of 174.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 38.00 Cr.. The value appears to be improving (decreasing). It has decreased from 39.00 Cr. (Mar 2024) to 38.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 521.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 334.00 Cr. (Mar 2024) to 521.00 Cr., marking an increase of 187.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 80.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 440.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2024) to 440.00 Cr., marking an increase of 184.00 Cr..
• For Total Assets, as of Mar 2025, the value is 521.00 Cr.. The value appears strong and on an upward trend. It has increased from 334.00 Cr. (Mar 2024) to 521.00 Cr., marking an increase of 187.00 Cr..

However, the Borrowings (275.00 Cr.) are higher than the Reserves (201.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Bhagyanagar India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 5. It has decreased from 14.29 (Mar 24) to 4.38, marking a decrease of 9.91.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 5. It has decreased from 14.29 (Mar 24) to 4.38, marking a decrease of 9.91.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.59. This value is within the healthy range. It has decreased from 16.36 (Mar 24) to 6.59, marking a decrease of 9.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.82. It has increased from 60.44 (Mar 24) to 64.82, marking an increase of 4.38.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.82. It has increased from 60.44 (Mar 24) to 64.82, marking an increase of 4.38.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 508.08. It has increased from 447.17 (Mar 24) to 508.08, marking an increase of 60.91.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 13.34. This value is within the healthy range. It has decreased from 23.73 (Mar 24) to 13.34, marking a decrease of 10.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.13. This value is within the healthy range. It has decreased from 21.65 (Mar 24) to 11.13, marking a decrease of 10.52.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.84. This value is within the healthy range. It has decreased from 17.46 (Mar 24) to 5.84, marking a decrease of 11.62.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.38. This value is within the healthy range. It has decreased from 14.29 (Mar 24) to 4.38, marking a decrease of 9.91.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.38. This value is within the healthy range. It has decreased from 14.29 (Mar 24) to 4.38, marking a decrease of 9.91.
• For PBDIT Margin (%), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 10. It has decreased from 5.30 (Mar 24) to 2.62, marking a decrease of 2.68.
• For PBIT Margin (%), as of Mar 25, the value is 2.19. This value is below the healthy minimum of 10. It has decreased from 4.84 (Mar 24) to 2.19, marking a decrease of 2.65.
• For PBT Margin (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 10. It has decreased from 3.90 (Mar 24) to 1.14, marking a decrease of 2.76.
• For Net Profit Margin (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 5. It has decreased from 3.19 (Mar 24) to 0.86, marking a decrease of 2.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 8. It has decreased from 3.19 (Mar 24) to 0.86, marking a decrease of 2.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 15. It has decreased from 23.64 (Mar 24) to 6.75, marking a decrease of 16.89.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.83. This value is within the healthy range. It has decreased from 27.31 (Mar 24) to 11.83, marking a decrease of 15.48.
• For Return On Assets (%), as of Mar 25, the value is 2.69. This value is below the healthy minimum of 5. It has decreased from 13.70 (Mar 24) to 2.69, marking a decrease of 11.01.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from 0.23 (Mar 24) to 0.38, marking an increase of 0.15.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.33. This value exceeds the healthy maximum of 1. It has increased from 0.52 (Mar 24) to 1.33, marking an increase of 0.81.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 3.81. It has increased from 3.78 (Mar 24) to 3.81, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has decreased from 3.18 (Mar 24) to 1.98, marking a decrease of 1.20.
• For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 1.27, marking a decrease of 0.87.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.54. This value exceeds the healthy maximum of 8. It has increased from 11.20 (Mar 24) to 12.54, marking an increase of 1.34.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 3. It has decreased from 5.66 (Mar 24) to 2.52, marking a decrease of 3.14.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 3. It has decreased from 4.41 (Mar 24) to 1.83, marking a decrease of 2.58.
• For Enterprise Value (Cr.), as of Mar 25, the value is 502.79. It has increased from 357.47 (Mar 24) to 502.79, marking an increase of 145.32.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 24) to 0.30, marking an increase of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 11.78. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 11.78, marking an increase of 7.07.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.14, marking a decrease of 0.04.
• For Price / BV (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has decreased from 1.35 (Mar 24) to 1.14, marking a decrease of 0.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.14, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.17 (Mar 24) to 0.05, marking a decrease of 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness